As of 11-2025, the promoter shareholding in Medinova Diagnostic Services - (Amalgamated) stands at 62.14% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Medinova Diagnostic Services - (Amalgamated) is 0% and 0% respectively.
The retail shareholding of the Medinova Diagnostic Services - (Amalgamated) is 37.86%.
Changes in shareholding patterns of Medinova Diagnostic Services - (Amalgamated) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Medinova Diagnostic Services - (Amalgamated) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.